| IN THE FEDERAL COURT OF AUSTRALIA | ) ) | ||
| NEW SOUTH WALES DISTRICT REGISTRY |
| ||
| ) |
| DIVISION | GENERAL | ) |
JANSSEN PHARMACEUTICA
PTY. LTD.
Applicant
PFIZER PTY. LTD.
Respondent
MINUTE OF ORDER OF THE COURT
Judqe Makins Order: Burchett J.
OF AUSTRAUA L.
| Date Order Made: | 19 November 1985 |
2 8 JAN 2003
| Where Made | : | Sydney |
THE COIJRT ORDERS THAT:
| (1) The | Respondent by' | itself | its | servants | and | agents | be |
| restrained from publishing | or | disseminating the video |
| recording entitled "Worms | - Knowledge & Treatment" ("the |
| video") and | the | manual | entitled | "Pfizer | Pharmacy |
| Reference Manual" | ( "the manual" | 1 and from causing | or |
permitting to be broadcast the television advertisement
made on behalf of the Respondent in relation to its
| product "Combantrin" | ( "the | television advertisement") |
| and such | of the radio advertisements broadcast | on behalf |
| of the Respondent | as suggest expressly | or by implication |
| that | there | three | a | common | human-infesting |
| gastro-intestinal | nematode | worms | in | Australia | ("the |
radio advertisements").
| The Respondent forthwith cause | such steps | to be taken as |
| may be necessary to recall and | procure to be redelivered |
2.
| to the Respondent all copies of the video and | so far as |
may be in its power the manual which have been published
and disseminated by the Respondent within Australia and
| to | prevent | the | future | broadcast | of | the | television |
advertisement and the radio advertisements.
| The | Respondent forthwith cause to be destroyed all |
copies of the video and the manual in its possession
| save for two | ( 2 ) copies of the video and five | ( 5 ) copies |
| of the manual which | it may keep €or its own record |
| purposes only, and forthwith upon recall | of any video or |
| manual | previously | disseminated | cause | such | video | or |
manual to be destroyed, destruction in respect of the
| video €or | the purposes of this order to include the |
wiping by magnetic means of the material recorded on the
cassette tape forming part of the video.
The Respondent by itself its servants and agents be restrained from without the prior leave of the Court
| publishing or making | by | any | medium | any | of | thc |
| representations | or | any | representations | which | are |
substantially the same as the representations set out in
| the Schedule to the Amended Application. | Where | a |
| representation in the Schedule | i s expressed | in | the |
alternative this order refers to each of the alternative
versions of the representation.
| (5) The Respondent | forthwith | inform | the | applicant | by |
| affidavit of all persons | to whom the Respondent | is aware |
| after all reasonable enquiry that | it has delivered or |
| caused t o be delivered a copy | of the video | or the manual |
| or either of them. |
| The Respondent | forthwith | cause | published | be | to |
| prominently in "Pharmacy Trade" and | "Australian Journal |
| of Pharmacy" an announcement in the | following terms:- |
"IMPORTANT ANNOUNCEMENT BY PFIZEX PTY.
LIMITED
| The Federal | Court of | Australia | has |
| ruled that Pfizer Pty. Limited | in | its |
| recent | advertising | and | promotion | of |
Combantrin has engaged in conduct that
| is misleading or | deceptive in that it |
| has made… |
Keep reading for free
Create a free CaseChat account to read Janssen Pharmaceutica v Pfizer Pty Ltd and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [1985] FCA 697
- Decision Date
CaseChat Overview and Summary
The court was required to determine whether the Respondent's advertising practices constituted misleading or deceptive conduct under the Trade Practices Act 1974 (Cth). The Applicant argued that the Respondent's statements were misleading and deceptive because they were false and likely to mislead consumers about the types of worms present in Australia and their prevalence. The Respondent, on the other hand, argued that their advertising materials did not contain any misleading or deceptive statements.
The court found in favour of the Applicant, holding that the Respondent's advertising practices constituted misleading or deceptive conduct. The court determined that the Respondent's statements were false and misleading, as there were at least five types of human-infesting gastro-intestinal nematode worms present in Australia, and only threadworm was common. The court also found that the Respondent's advertising materials were likely to mislead consumers about the types of worms present in Australia and their prevalence.
The court issued an order restraining the Respondent from publishing or disseminating the video recording entitled "Worms - Knowledge & Treatment," the manual entitled "Pfizer Pharmacy Reference Manual," and from broadcasting the television and radio advertisements made on behalf of the Respondent. The Respondent was also required to recall and destroy all copies of the video and manual that had been published and disseminated within Australia. The Respondent was further ordered to inform the Applicant of all persons to whom they had delivered or caused to be delivered a copy of the video or manual or either of them. The Respondent was also required to publish an announcement in "Pharmacy Trade" and "Australian Journal of Pharmacy" and a national daily newspaper, informing the public of the court's ruling and requesting that pharmacists cease further distribution and use of the promotional materials. The Respondent was also ordered to pay the Applicant's costs of the proceedings.
In summary, the court held that the Respondent's advertising practices constituted misleading or deceptive conduct under the Trade Practices Act 1974 (Cth) and issued an order to restrain the Respondent from further disseminating the misleading information and to take steps to recall and destroy the promotional materials.
Background
Background to the litigation
The case was heard in the Federal Court of Australia, New South Wales District Registry. Janssen Pharmaceutica Pty. Ltd. was the applicant and Pfizer Pty. Ltd. was the respondent. The matter was brought before the court seeking injunctive relief and damages. The court heard evidence and submissions from both parties, and subsequently delivered its judgment and orders.
Decision
Reasons for decision
1. Whether Pfizer Pty. Ltd. engaged in conduct that was misleading or deceptive in its advertising and promotional materials for "Combantrin".
2. Whether an injunction should be granted to restrain Pfizer Pty. Ltd. from disseminating or broadcasting the contested promotional materials.
3. What form of corrective advertising or public announcements Pfizer Pty. Ltd. should be required to undertake to rectify the misleading statements.
4. Whether Pfizer Pty. Ltd. should be ordered to pay Janssen Pharmaceutica Pty. Ltd.'s costs of the proceedings.
Held
1. The Court concluded that Pfizer Pty. Ltd. engaged in conduct that was misleading or deceptive in its advertising and promotional materials for "Combantrin".
2. The Court granted an injunction to restrain Pfizer Pty. Ltd. from disseminating or broadcasting the contested promotional materials.
3. The Court required Pfizer Pty. Ltd. to undertake specified forms of corrective advertising and public announcements to rectify the misleading statements.
4. The Court ordered Pfizer Pty. Ltd. to pay Janssen Pharmaceutica Pty. Ltd.'s costs of the proceedings.
Ratio Decidendi
Legal Principle Established
The Federal Court examined the advertising and promotional materials produced by Pfizer Pty. Ltd. for their product "Combantrin" and found that these materials contained statements and representations that were misleading or deceptive. The Court identified two key areas of misleading conduct: first, the claim that there were only three types of human-infesting gastro-intestinal nematode worms in Australia, when in fact there are at least five such types; and second, the assertion that threadworm, roundworm, and hookworm are common in Australia, when in reality only threadworm is common and roundworm and hookworm are extremely rare. The Court relied on evidence presented by Janssen Pharmaceutica Pty. Ltd. to substantiate these claims of misleading conduct. In granting an injunction, the Court aimed to prevent further dissemination of the misleading materials and to ensure compliance with the corrective measures. The Court ordered Pfizer Pty. Ltd. to recall and destroy all copies of the promotional materials, cease broadcasting the contested advertisements, and publish corrective announcements in specified professional and national media outlets. This was intended to rectify the misleading information and inform the public and industry stakeholders of the Court's findings. Finally, the Court ordered Pfizer Pty. Ltd. to pay Janssen Pharmaceutica Pty. Ltd.'s costs of the proceedings, reflecting the legal principle that the losing party in proceedings of this nature may be required to compensate the successful party for the costs incurred.